Chalazion on the Eyelid: Causes, Treatments, and Remedies

What is Chalazion?

A chalazion is a localized, non-infectious cyst of the eyelid that appears as a visible swelling. It is caused by the chronic inflammation and obstruction of one of the Meibomian glands: the tiny specialized sebaceous (oil-producing) glands embedded within both the upper and lower eyelids. Each eyelid contains approximately 25 to 40 of these glands. They are arranged in a single row along the length of the lid and secrete the oily outer layer of the tear film. This lipid layer prevents rapid evaporation of tears and helps keep the surface of the eye lubricated and protected.

When a Meibomian gland becomes blocked, its oily secretion cannot drain normally onto the surface of the eye. The secretion accumulates within the gland, hardens, and eventually causes the gland to enlarge. This process produces the characteristic firm, round, non-tender nodule beneath the skin of the eyelid, which we recognize clinically as a chalazion.

The swelling is typically localized and well-defined, ranging in size from barely perceptible (about the size of a pinhead) to as large as a pea or occasionally even larger. It is always visible beneath the skin of the eyelid rather than on its surface.

A chalazion is a non-infectious, inflammatory condition. It occurs when sebaceous secretions are retained, triggering a granulomatous tissue reaction, rather than being caused by bacteria. However, the obstructed gland can occasionally become secondarily infected by bacteria, transforming the condition into a more acutely painful, inflamed presentation.

Fortunately, the vast majority of chalazia are benign and self-limiting. Small chalazia often resolve entirely on their own without any treatment within a few weeks to months. Even larger or persistent ones respond well to appropriate management. The condition carries an excellent prognosis and typically evolves toward complete resolution without significant complications.

It is important to note that chalazion is sometimes confused with a stye (hordeolum), another condition that causes eyelid swelling. While both produce visible lumps on the eyelid, they are distinct conditions with different causes, characteristics, and management approaches, as described in detail below.

---

Causes

The formation of a chalazion follows a predictable physiological sequence rooted in the dysfunction of the Meibomian glands:

The Pathophysiology of Chalazion Formation

1. Meibomian gland obstruction: The process begins when the ductal opening (the small pore through which the gland’s oily secretion drains onto the eyelid margin) becomes obstructed or when the secretion itself becomes too thick and viscous to flow normally through the duct. This can result from abnormalities in the chemical composition of the meibum (the glandular secretion), excessive keratinization of the duct lining, or mechanical blockage.

2. Secretion retention and gland enlargement: Because the gland continues to produce meibum despite the blocked duct, the secretion accumulates within the gland itself, causing it to gradually enlarge as pressure within the gland increases.

3. Rupture and granulomatous inflammation: Eventually, the distended gland wall can rupture, releasing its oily contents into the surrounding eyelid tissue. The immune system recognizes this sebaceous material as foreign. In response, it triggers a chronic granulomatous inflammatory reaction, which involves recruiting macrophages and other immune cells. These cells attempt to engulf and break down the material. This granulomatous response is responsible for the firm, encapsulated nodule characteristic of a chalazion.

The contents of a chalazion typically include a mixture of inspissated (thickened) meibum, pus cells, and the granulomatous tissue of the inflammatory reaction.

What Causes Meibomian Gland Dysfunction?

The precise trigger for Meibomian gland obstruction is not always identifiable. However, certain conditions are well-established as predisposing factors:

• Blepharitis: Chronic inflammation of the eyelid margins, which is the most important risk factor for chalazion. Blepharitis produces changes in the composition and consistency of meibum (making it thicker and more prone to obstruction), bacterial biofilm along the eyelid margin, and structural changes to the Meibomian gland ducts. Individuals with blepharitis are significantly more prone to recurrent chalazia.

• Rosacea: This chronic inflammatory skin condition frequently involves the eyelids (a condition called ocular rosacea), affecting Meibomian gland function and predisposing to chalazion formation. The mechanism involves inflammation-driven changes in meibum composition and secretion.

• Seborrheic dermatitis: Closely associated with blepharitis, seborrheic dermatitis of the scalp and face can contribute to abnormal sebaceous gland function at the eyelid margin.

• Demodex mite infestation: Microscopic mites of the genus Demodex, specifically Demodex folliculorum and Demodex brevis, are natural inhabitants of human hair follicles and sebaceous glands. In excessive numbers, they can colonize the eyelash follicles and Meibomian gland openings, causing local irritation, blockage of the gland ducts, and predisposition to chalazion formation. Demodex infestation is increasingly recognized as an important and underdiagnosed contributing factor in recurrent chalazia.

• Hormonal factors: Changes in hormonal status, such as those during puberty, pregnancy, and menopause, can alter the composition of sebaceous secretions throughout the body. This includes the Meibomian glands and may potentially increase the risk of chalazion.

• Systemic medications: Certain medications can alter Meibomian gland function as a side effect. These include isotretinoin, which is used for acne treatment, some chemotherapy agents, and immunosuppressants.

• High-lipid diet: Some evidence suggests that diets very high in certain fats may alter the composition of meibum, though this association is not definitively proven.

• Immunosuppression: Individuals with weakened immune systems, whether due to disease or immunosuppressive medications, may be more susceptible to chalazion formation and recurrence.

Is a Chalazion the Same as a Stye?

One of the most common questions patients ask is whether these conditions are the same. The answer is no, they are distinct conditions, even though they can appear similar and are sometimes mistaken for one another. Understanding the differences is important for appropriate management:

A further useful distinction: an internal hordeolum (a stye originating in a Meibomian gland) can look very similar to a chalazion and is sometimes differentiated only by its more acute, painful presentation. It is important to note that an untreated or incompletely resolved internal hordeolum can transform into a chalazion over time, as the acute bacterial inflammation transitions to a chronic granulomatous reaction.

---

Symptoms

The clinical presentation of a chalazion is generally straightforward and recognizable. The characteristic features include:

The Primary Finding: Eyelid Nodule

The defining feature of a chalazion is the firm, round, movable nodule within the body of the eyelid. Key characteristics:

• Size: Highly variable, ranging from barely perceptible (pinhead-sized) to the size of a pea, approximately 5–8 mm, or occasionally larger.
• Location: Typically within the body of the eyelid, known as the tarsal plate. It is positioned away from the free eyelid margin, which distinguishes it from a stye. A stye usually presents at the margin itself.
• Consistency: Firm and well-defined on palpation, with a distinct capsule.
• Mobility: When touched, the nodule moves freely with the eyelid skin. It is not fixed to deeper structures.
• Color: The overlying skin is usually normal in color, or may show mild diffuse redness without localized inflammation.

Associated Symptoms

In addition to the visible and palpable nodule, patients may experience:

• Eyelid swelling: The affected eyelid may appear generally swollen, particularly in the early stages when surrounding tissue edema is more prominent.
• Redness: Mild, diffuse redness of the eyelid skin surrounding the nodule; not typically as intense or localized as in a stye.
• A sense of heaviness or fullness in the eyelid: The patient may describe the eyelid as feeling heavy, weighted, or thicker than normal.
• Blurred vision: When a chalazion becomes large, it may press on the cornea, the clear front surface of the eye. This pressure can cause astigmatism, a condition where the cornea’s curvature becomes distorted, leading to blurred or unclear vision. This is one of the most important functional complications and a key indication for treatment, particularly in children. During the critical period of visual development, induced astigmatism can contribute to amblyopia, also known as “lazy eye”.
• Mild discomfort: Some patients report a mild aching or pressure sensation in the affected eyelid, though significant pain is unusual in an uncomplicated chalazion. The presence of moderate-to-severe pain should raise the possibility of a secondary bacterial infection.

Natural History

Without treatment, the natural history of a chalazion follows one of several trajectories:

• Spontaneous resolution: Many small chalazia resolve entirely on their own within 4 to 8 weeks, as the body’s macrophages gradually break down and reabsorb the retained meibum and granulomatous tissue. This is more likely in smaller lesions and in patients without underlying conditions like blepharitis or rosacea.
• Persistence without growth: Some chalazia remain stable. They neither grow nor resolve and may persist for months without causing significant symptoms.
• Enlargement: Others continue to enlarge, potentially causing increased discomfort, functional visual impact, or cosmetic concern, warranting intervention.
• Spontaneous pointing and drainage: Occasionally, a chalazion may spontaneously rupture through the conjunctival surface (the inner surface of the eyelid), draining its contents and then gradually resolving. This is generally not associated with scarring.

---

When to See a Doctor

While many chalazia can be safely managed at home with warm compresses and eyelid hygiene, the following situations warrant prompt evaluation by a general practitioner or, preferably, an ophthalmologist:

• A lump or swelling on the eyelid that is new, growing, or persisting beyond 4–6 weeks despite home treatment
• Loss of eyelashes in a localized area: an important warning sign that should be evaluated to exclude malignant conditions (see “Risks and Complications”)
• Symptoms suggesting secondary infection:
  • Increasing redness and warmth of the eyelid
  • Significant pain or tenderness
  • Discharge of pus from the eyelid
  • Fever or malaise (suggesting spread of infection, such as preseptal or orbital cellulitis)
• Visual disturbances: blurred or distorted vision
• Rapid growth of the lesion
• Recurrence in the same location particularly relevant because a lesion that repeatedly recurs in exactly the same spot despite adequate treatment should raise suspicion for a Meibomian gland carcinoma (see below)
• Chalazion in a child: pediatric chalazia warrant earlier evaluation because of the risk of amblyopia from pressure-induced astigmatism
• Uncertainty about the diagnosis: if there is any doubt about whether the lesion is a chalazion or something else

---

Risks and Complications

The overall prognosis for chalazion is excellent. The vast majority of cases resolve completely, either spontaneously or with appropriate treatment, without lasting consequences. Nevertheless, a small number of possible complications deserve awareness:

Minor Complications

• Cosmetic impact: During the active phase, the eyelid swelling may be cosmetically distressing, particularly if the chalazion is large or located in a prominent position.

• Eyelid scarring: Although the chalazion itself rarely causes significant scarring, surgical excision carries a small risk of leaving a subcutaneous scar within the eyelid tissue. This is generally minimized by the use of the internal (transconjunctival) surgical approach, which leaves no visible external scar.

• Eyelash loss: A chalazion that causes significant local tissue disruption may result in localized loss of eyelashes in the affected area, or the development of a small marginal lesion at the eyelid border.

Recurrence

Recurrence is the most clinically common “complication” of chalazion. The underlying predisposing conditions, particularly blepharitis, rosacea, Demodex infestation, and Meibomian gland dysfunction, often persist after individual chalazia resolve. This creates a tendency for new chalazia to form. This is why treating the underlying condition (e.g., managing blepharitis with regular eyelid hygiene) is essential for long-term prevention.

Vision Impairment

In larger chalazia, particularly in children, the pressure exerted on the cornea can induce significant astigmatism, causing blurred or distorted vision. In children under 8 years of age, during the sensitive period of visual development, persistent, untreated pressure on the cornea can contribute to amblyopia (lazy eye), a permanent reduction in best-corrected visual acuity if not addressed promptly.

Secondary Bacterial Infection

Though a chalazion is inherently non-infectious, the obstructed gland is susceptible to secondary bacterial infection, converting the condition into an infected chalazion or internal hordeolum. Signs of secondary infection include increased pain, redness, warmth, and purulent discharge.

Meibomian Gland Carcinoma: The Critical Differential Diagnosis

This is the most important complication to be aware of, and it is the primary reason why recurrent chalazia in the same location should never be dismissed.

Sebaceous gland carcinoma (also known as Meibomian gland carcinoma) is a rare but aggressive malignant tumor of the eyelid that can masquerade clinically as a recurrent or atypical chalazion. Key warning features that should prompt urgent ophthalmological evaluation and biopsy include:

• Recurrence of a chalazion in the same location despite adequate treatment
• Unilateral blepharitis that does not respond to treatment: sebaceous carcinoma can spread along the conjunctiva and present as a diffuse, treatment-resistant unilateral blepharitis
• Eyelash loss (madarosis) at the site of the lesion
• A hard, indurated (firm), irregular nodule rather than the typical soft-to-firm, smooth, well-encapsulated chalazion
• Older patient age (sebaceous carcinoma occurs predominantly in older adults)
• History of radiation therapy to the periocular area

When any of these features are present, histopathological examination (biopsy) of the excised tissue is mandatory. Indeed, many ophthalmologists routinely send all chalazion excision specimens for pathological analysis, particularly in older patients or in cases with atypical features.

---

Diagnosis

The diagnosis of chalazion is primarily clinical, established through a careful history and direct visual and tactile examination of the eyelid by the examining clinician (GP or ophthalmologist). No laboratory tests or imaging studies are typically required for straightforward cases.

Clinical Examination

The ophthalmologist or GP examines the eyelid with the aid of good lighting and, if available, a slit-lamp biomicroscope (an instrument providing magnified illumination of the anterior eye and eyelids). Key examination findings include:

• External inspection: A firm, round, smooth swelling within the body of the eyelid, lifting and distorting the eyelid contour
• Eyelid eversion (turning the eyelid inside out): By everting the upper or lower eyelid, the examiner can view the inner (conjunctival) surface of the eyelid. In chalazion, the corresponding area of the inner eyelid surface typically shows a localized elevation of the conjunctiva, often with a yellowish or grayish tinge reflecting the lipid contents beneath
• Palpation: The lesion is assessed for size, consistency, tenderness, and mobility
• Assessment of eyelid margin: To exclude primary blepharitis, eyelash loss, or other marginal abnormalities
• Assessment of visual acuity and corneal shape: In larger chalazia, particularly in children, measurement of visual acuity and, if indicated, corneal topography may be performed to assess whether the chalazion is inducing corneal astigmatism

When Is Additional Investigation Required?

In atypical or recurrent cases, the ophthalmologist may recommend:

• Histopathological examination (biopsy): Any excised chalazion tissue, particularly from a recurrent lesion, a lesion associated with eyelash loss, or a lesion with atypical clinical features, should be sent for microscopic analysis to exclude Meibomian gland carcinoma.
• Skin swabs or cultures: If secondary bacterial infection is suspected, a swab of purulent discharge may be taken for microbiological culture and sensitivity testing to guide antibiotic selection.

---

Treatment and Therapy

The treatment approach for chalazion is tailored to the size of the lesion, the presence or absence of symptoms, and the duration of the condition. Management ranges from watchful waiting and simple home remedies to office-based procedures and surgical intervention.

Watchful Waiting (Observation)

For small, asymptomatic chalazia, particularly those that are newly formed, a period of watchful waiting combined with conservative home management is entirely appropriate. Many such lesions resolve spontaneously within 4–8 weeks without any intervention.

Warm Moist Compresses: The First-Line Treatment

Warm moist compress therapy is the cornerstone of first-line chalazion management and is recommended by the vast majority of ophthalmologists as the initial approach for all uncomplicated chalazia.

How it works: Applying warmth to the eyelid raises the local temperature of the eyelid tissue, which lowers the viscosity (thickness) of the retained meibum within the blocked gland. When the solidified, obstructing secretion is sufficiently warmed and softened, it may begin to flow freely through the duct again. This allows the gland to empty, the inflammation to subside, and the chalazion to resolve.

How to perform warm compress therapy correctly:

1. Wash your hands thoroughly before touching the eyelid area.
2. Heat water to a comfortable but not scalding temperature (approximately 40–45°C / 104–113°F). The water should feel pleasantly warm, not painful, when tested on the inside of the wrist.
3. Saturate a clean flannel cloth, washcloth, or sterile gauze with the warm water and wring out the excess.
4. Close your eye and gently place the warm compress over the affected eyelid.
5. Hold in place for 10 to 15 minutes, reheating the compress as needed to maintain warmth.
6. Repeat at least 4 times per day. The frequency and consistency of application are more important than any single session duration.
7. After each warm compress session, gently massage the eyelid in the direction of the eyelid margin (from the base of the lashes toward the tip) to help express the softened contents of the gland.

Some patients find commercially available heated eye masks (microwavable or electrically heated) more convenient, as they maintain a consistent temperature throughout the session.

Important: Do not use excessively hot compresses, as the temperature must be safe for the delicate skin around the eye. Never use ice or cold compresses for a chalazion.

Eyelid Hygiene and Massage

Combining warm compresses with daily eyelid hygiene significantly enhances treatment efficacy and reduces the likelihood of recurrence:

• After each warm compress session, use a commercially available eyelid scrub pad, sterile cotton bud, or diluted baby shampoo on a cotton pad to gently clean the eyelid margin, removing adherent sebaceous debris, crusts, and bacterial biofilm from around the eyelash bases and gland openings.
• Eyelid massage following warm compresses can be performed by gently rolling a cotton bud along the eyelid in the direction of the gland drainage, helping to express softened contents.

Topical Antibiotics

Topical antibiotic creams or eye drops are generally unnecessary and ineffective for a non-complicated chalazion, because chalazion is an inflammatory rather than an infectious process. However, they are indicated when there is evidence of secondary bacterial infection (e.g., increasing pain, redness, warmth, or purulent discharge). In such cases, topical antibiotic preparations (such as chloramphenicol, fusidic acid, or fluoroquinolone drops) may be prescribed.

Corticosteroid Injection

For chalazia that fail to respond to several weeks of warm compress therapy, or for patients seeking faster resolution, intralesional corticosteroid injection offers an effective and minimally invasive office-based treatment option.

How it works: A small volume of a corticosteroid solution, typically triamcinolone acetonide, is injected directly into the chalazion (either through the skin surface or through the inner conjunctival surface). Corticosteroids are potent anti-inflammatory agents that suppress the granulomatous inflammatory reaction within the chalazion, allowing the lesion to progressively shrink and eventually resolve.

Efficacy: Studies report resolution rates of approximately 50–80% following a single injection, with some patients requiring a second injection after 4–6 weeks if the initial response is partial.

Advantages over surgery:

• No incision required
• Rapid procedure (performed in the outpatient clinic in minutes)
• Lower risk of eyelid scarring compared to surgery
• No need for anesthesia

Disadvantages and potential side effects:

• Possible skin depigmentation at the injection site, particularly relevant in patients with darker skin tones. Depigmentation appears as a lighter patch of skin overlying the chalazion and may be temporary or permanent.
• Elevated intraocular pressure: corticosteroids can raise eye pressure, which is relevant in patients with glaucoma or a history of steroid-responsive ocular hypertension.
• Incomplete resolution: not all chalazia respond fully to injection.
• The procedure can be mildly uncomfortable, particularly in the lower eyelid.

Surgical Excision (Incision and Curettage)

For large, persistent, or rapidly growing chalazia that do not respond adequately to conservative management or corticosteroid injection, surgical excision is the definitive treatment.

The procedure:

• Performed as an outpatient (day surgery) procedure, typically under local anesthesia (a small injection of local anesthetic into the eyelid) and light sedation if required
• The surgeon everts the eyelid (turns it inside out) to access the chalazion from the inner (conjunctival) surface, rather than through the outer skin surface. This approach avoids leaving any visible external scar on the eyelid skin.
• A small incision is made in the conjunctiva overlying the chalazion.
• The contents of the chalazion and the surrounding capsule are carefully curetted (scooped out) and excised.
• In most cases, no sutures are required; the small incision heals naturally.
• The excised material is sent to a pathologist for histological examination to exclude malignancy.

Patients can usually return to normal activities within a day or two, though mild eyelid swelling and bruising are common for several days after the procedure.

What to Avoid

• Do not attempt to squeeze or pop a chalazion. Unlike a stye, which may point and discharge naturally, a chalazion has a fibrous capsule that makes self-expression harmful and ineffective. Squeezing can damage surrounding tissue, introduce bacteria, and worsen inflammation.
• Avoid wearing contact lenses during active treatment and healing, as they may exacerbate irritation and increase infection risk.
• Avoid heavy makeup on the affected eyelid during the active phase.

---

Prevention

While it is not always possible to completely prevent chalazia, especially in individuals with underlying predisposing conditions, several practical measures can significantly reduce the risk of initial development and, crucially, recurrence.

Daily Eyelid Hygiene

This is the single most effective preventive measure, particularly for patients with a history of recurrent chalazia or underlying blepharitis:

• Clean the eyelid margins daily using commercially available periocular hygiene wipes (specifically formulated for eyelid cleaning and free from harsh detergents), or a diluted baby shampoo solution on a clean cotton pad or bud.
• This removes the accumulated sebaceous debris, bacterial biofilm, and Demodex-related products that contribute to Meibomian gland obstruction.
• Consistency is key. Daily eyelid hygiene, when performed long-term, is significantly more effective than intermittent cleansing.

Management of Underlying Conditions

Effectively treating the conditions that predispose to chalazion formation dramatically reduces recurrence risk:

• Blepharitis: Long-term eyelid hygiene and warm compresses are essential. When indicated, topical or oral antibiotics, such as azithromycin ointment or oral doxycycline, may also be used for their anti-inflammatory and antimicrobial effects.
• Rosacea: Dermatological management of rosacea reduces the ocular component and associated Meibomian gland dysfunction.
• Demodex infestation: Treatments targeting Demodex, such as tea tree oil-based eyelid products, in-office treatments, and newly approved topical lotions, can reduce the mite burden and associated gland dysfunction.

Long-Term Antibiotic Therapy for Recurrent Chalazion

For patients who continue to experience frequent recurrences even after maintaining proper eyelid hygiene and managing underlying conditions, an ophthalmologist may recommend long-term, low-dose oral antibiotic therapy. The most commonly prescribed antibiotic in these cases is doxycycline, which belongs to the tetracycline class. At low doses, doxycycline produces significant anti-inflammatory effects on the Meibomian glands. It modifies the composition of meibum, reduces inflammation, and improves gland function. Importantly, these effects occur without relying on its antibacterial properties. Treatment courses typically last several months.

Alternatively, long-term topical antibiotic preparations may be considered as part of a preventive regimen in selected patients.

Dietary Considerations

Some evidence suggests that a diet rich in omega-3 fatty acids (found in oily fish such as salmon, mackerel, and sardines; walnuts; flaxseed; and chia seeds) may improve Meibomian gland function by altering the fatty acid composition of meibum, making it less viscous and less prone to obstruction. While the evidence is not yet definitive, increasing omega-3 intake is a safe and potentially beneficial dietary modification for patients with recurrent chalazia.

Contact Lens Hygiene and Practices

Contact lens wearers should ensure meticulous lens hygiene. Always wash hands before handling lenses, use fresh solution, replace lenses and cases as directed, and never sleep in lenses unless a doctor has specifically prescribed them as extended-wear. Poorly maintained contact lenses can contribute to eyelid margin inflammation and increase chalazion risk.

Avoid Touching and Rubbing the Eyes

Habitual eye rubbing and touching can introduce bacteria to the eyelid margin, disrupt the Meibomian gland openings, and traumatize the delicate periocular tissue. These actions all contribute to chalazion formation. Identifying and addressing the cause of eye itching (e.g., allergic eye disease) can reduce the urge to rub.

---

Sources and Bibliography

• University of Michigan Kellogg Eye Center. Chalazion and Stye. Available at: https://www.umkelloggeye.org/conditions-treatments/chalazion-stye
• National Institutes of Health (NIH), MedlinePlus. Chalazion. Available at: https://medlineplus.gov/ency/article/001006.htm
• American Academy of Ophthalmology (AAO). Chalazion. EyeWiki. Available at: https://eyewiki.aao.org/Chalazion
• Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach. 8th ed. Edinburgh: Elsevier; 2016.
• Gilchrist H, Lee G. Management of chalazia in general practice. Australian Family Physician. 2009;38(5):311–314.
• Ho S, Ni D. Chalazion. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.
• Ben Simon GJ, Huang L, Nakra T, et al. Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really effective? Ophthalmology. 2005;112(5):913–917.
• Cunniffe G, Gupta M. Chalazion management: current and future options. Clinical and Experimental Ophthalmology. 2023.
• Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on Meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the Meibomian gland. Investigative Ophthalmology and Visual Science. 2011;52(4):1938–1978.